Literature DB >> 12432313

The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns.

R A Cooper1, E Halas, P C Molan.   

Abstract

Because there is no ideal therapy for burns infected with Pseudomonas aeruginosa, there is sufficient need to investigate the efficacy of alternative antipseudomonal interventions. Honey is an ancient wound remedy for which there is modern evidence of efficacy in the treatment of burn wounds, but limited evidence for the effectiveness of its antibacterial activity against Pseudomonas. We tested the sensitivity of 17 strains of P. aeruginosa isolated from infected burns to two honeys with different types of antibacterial activity, a pasture honey and a manuka honey, both with median levels of activity. All strains showed similar sensitivity to honey with minimum inhibitory concentrations below 10% (vol/vol); both honeys maintained bactericidal activity when diluted more than 10-fold. Honey with proven antibacterial activity has the potential to be an effective treatment option for burns infected or at risk of infection with P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432313     DOI: 10.1097/00004630-200211000-00002

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  38 in total

1.  The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis.

Authors:  S E Blair; N N Cokcetin; E J Harry; D A Carter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-10       Impact factor: 3.267

Review 2.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

Review 3.  Honey: its medicinal property and antibacterial activity.

Authors:  Manisha Deb Mandal; Shyamapada Mandal
Journal:  Asian Pac J Trop Biomed       Date:  2011-04

4.  The effect of manuka honey on the structure of Pseudomonas aeruginosa.

Authors:  A F Henriques; R E Jenkins; N F Burton; R A Cooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-10       Impact factor: 3.267

Review 5.  Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology.

Authors:  Arne Simon; Kai Sofka; Gertrud Wiszniewsky; Gisela Blaser; Udo Bode; Gudrun Fleischhack
Journal:  Support Care Cancer       Date:  2005-08-02       Impact factor: 3.603

6.  The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey.

Authors:  S M Lin; P C Molan; R T Cursons
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-26       Impact factor: 3.267

7.  Honey in wound care: antibacterial properties.

Authors:  Rose Cooper
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-12-28

8.  Wound contraction effects and antibacterial properties of Tualang honey on full-thickness burn wounds in rats in comparison to hydrofibre.

Authors:  Yan-Teng Khoo; Ahmad Sukari Halim; Kirnpal-Kaur B Singh; Noor-Ayunie Mohamad
Journal:  BMC Complement Altern Med       Date:  2010-09-03       Impact factor: 3.659

9.  The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.

Authors:  Lei Zhang; Sunil V Badve; Elaine M Pascoe; Elaine Beller; Alan Cass; Carolyn Clark; Janak de Zoysa; Nicole M Isbel; Steven McTaggart; Alicia T Morrish; E Geoffrey Playford; Anish Scaria; Paul Snelling; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

10.  The intracellular effects of manuka honey on Staphylococcus aureus.

Authors:  A F Henriques; R E Jenkins; N F Burton; R A Cooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-10-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.